{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:28:34Z","timestamp":1777426114327,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001742","name":"Binational Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israeli Science Foundation","doi-asserted-by":"crossref","award":["175\/13"],"award-info":[{"award-number":["175\/13"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Rudin Fellowship Trust"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jmb.2016.08.007","type":"journal-article","created":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T02:00:06Z","timestamp":1470967206000},"page":"4209-4217","source":"Crossref","is-referenced-by-count":15,"title":["Mapping the Resistance Potential of Influenza's H+ Channel against an Antiviral Blocker"],"prefix":"10.1016","volume":"428","author":[{"given":"Dror","family":"Assa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael","family":"Alhadeff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Krugliak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaiah T.","family":"Arkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jmb.2016.08.007_bb0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1261\/rna.045369.114","article-title":"Comparative mutational analyses of influenza A viruses","volume":"21","author":"Cheung","year":"2015","journal-title":"Rna"},{"key":"10.1016\/j.jmb.2016.08.007_bb0010","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1021\/jm500598u","article-title":"Aminoadamantanes with persistent in vitro efficacy against h1n1 (2009) influenza a","volume":"57","author":"Kolocouris","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2016.08.007_bb0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0166-3542(97)00061-2","article-title":"How to overcome resistance of influenza a viruses against adamantane derivatives","volume":"37","author":"Scholtissek","year":"1998","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jmb.2016.08.007_bb0020","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03883","article-title":"Improving pandemic influenza risk assessment","volume":"3","author":"Russell","year":"2014","journal-title":"Elife,"},{"key":"10.1016\/j.jmb.2016.08.007_bb0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fpubh.2014.00077","article-title":"The irrationality of GOF avian influenza virus research","volume":"2","author":"Wain-Hobson","year":"2014","journal-title":"Front. Public Health"},{"key":"10.1016\/j.jmb.2016.08.007_bb0030","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1126\/science.144.3620.862","article-title":"Antiviral activity of 1-adamantanamine (amantadine)","volume":"144","author":"Davies","year":"1964","journal-title":"Science,"},{"key":"10.1016\/j.jmb.2016.08.007_bb0035","first-page":"553","article-title":"Antiviral activity of alpha-methyl-1-adamantanemethylamine hydrochloride","volume":"5","author":"Tsunoda","year":"1965","journal-title":"Antimicrob. Agents. Chemother. (Bethesda),"},{"key":"10.1016\/j.jmb.2016.08.007_bb0040","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.coviro.2011.09.002","article-title":"Antivirals and resistance: influenza virus","volume":"1","author":"Ison","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jmb.2016.08.007_bb0045","doi-asserted-by":"crossref","first-page":"11,872","DOI":"10.1021\/bi9014488","article-title":"Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus","volume":"48","author":"Balannik","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2016.08.007_bb0050","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(05)67338-2","article-title":"Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern","volume":"366","author":"Bright","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jmb.2016.08.007_bb0055","unstructured":"Centers for Disease Control and Prevention, 2013. Influenza Type A Viruses and Subtypes \u2014 Avian Influenza (Flu)."},{"key":"10.1016\/j.jmb.2016.08.007_bb0060","unstructured":"Centers for Disease Control and Prevention, 2014. a. Information on Avian Influenza \u2014 Avian Influenza (Flu)."},{"key":"10.1016\/j.jmb.2016.08.007_bb0065","unstructured":"Centers for Disease Control and Prevention, 2014 b. Summary Recommendations: Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices\u2014(ACIP)\u2014United States, 2013\u201314 \u2014 Health Professionals \u2014 Seasonal Influenza (Flu)."},{"key":"10.1016\/j.jmb.2016.08.007_bb0070","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/B978-0-12-405880-4.00006-8","article-title":"Influenza virus resistance to antiviral therapy","volume":"67","author":"van der Vries","year":"2013","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.jmb.2016.08.007_bb0075","unstructured":"Fiore, A. E., Fry, A., Shay, D., Gubareva, L., Bresee, J. S., Uyeki, T. M., 2011. Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza - Recommendations of the Advisory Committee on Immunization Practices. Tech. Rep. 1, Centers for Disease Control and Prevention."},{"key":"10.1016\/j.jmb.2016.08.007_bb0080","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/095632020601700502","article-title":"Rimantadine and oseltamivir demonstrate synergistic combination effect in an experimental infection with type A (H3N2) influenza virus in mice","volume":"17","author":"Galabov","year":"2006","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.jmb.2016.08.007_bb0085","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/135965350701200302","article-title":"Amantadine\u2013oseltamivir combination therapy for H5N1 influenza virus infection in mice","volume":"12","author":"Ilyushina","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jmb.2016.08.007_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009332","article-title":"Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro","volume":"5","author":"Nguyen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jmb.2016.08.007_bb0095","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3851\/IMP2475","article-title":"Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics","volume":"18","author":"Seo","year":"2013","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jmb.2016.08.007_bb0100","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1002\/j.1460-2075.1985.tb04038.x","article-title":"The molecular basis of the specific anti-influenza action of amantadine","volume":"4","author":"Hay","year":"1985","journal-title":"EMBO J."},{"key":"10.1016\/j.jmb.2016.08.007_bb0105","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1073\/pnas.94.10.5000","article-title":"The active oligomeric state of the minimalistic influenza virus M2 ion channel is a tetramer","volume":"94","author":"Sakaguchi","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.jmb.2016.08.007_bb0110","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0092-8674(92)90452-I","article-title":"Influenza virus M2 protein has ion channel activity","volume":"69","author":"Pinto","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2016.08.007_bb0115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0092-8674(91)90576-K","article-title":"Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import","volume":"67","author":"Martin","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2016.08.007_bb0120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1126\/science.1094823","article-title":"How viruses enter animal cells","volume":"304","author":"Smith","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jmb.2016.08.007_bb0125","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nature08722","article-title":"Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers","volume":"463","author":"Cady","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2016.08.007_bb0130","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nature06528","article-title":"Structural basis for the function and inhibition of an influenza virus proton channel","volume":"451","author":"Stouffer","year":"2008","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.jmb.2016.08.007_bb0135","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.1216526110","article-title":"Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmb.2016.08.007_bb0140","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1021\/bi901799k","article-title":"Functional studies and modeling of pore-lining residue mutants of the influenza a virus M2 ion channel","volume":"49","author":"Balannik","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2016.08.007_bb0145","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0042-6822(92)90229-I","article-title":"Influence of amantadine resistance mutations on the pH regulatory function of the M2 protein of influenza A viruses","volume":"191","author":"Grambas","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.jmb.2016.08.007_bb0150","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1128\/jvi.68.3.1551-1563.1994","article-title":"Influenza A virus M2 ion channel protein: a structure\u2013function analysis","volume":"68","author":"Holsinger","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2016.08.007_bb0155","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s002030050425","article-title":"Requirement of a large K+-uptake capacity and of extracytoplasmic protease activity for protamine resistance of Escherichia coli","volume":"167","author":"Stumpe","year":"1997","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.jmb.2016.08.007_bb0160","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.bbamem.2010.08.021","article-title":"Quantitative analysis of influenza M2 channel blockers","volume":"1808","author":"Astrahan","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jmb.2016.08.007_bb0165","doi-asserted-by":"crossref","first-page":"15,075","DOI":"10.1073\/pnas.1007071107","article-title":"Structure and mechanism of proton transport through the transmembrane tetrameric m2 protein bundle of the influenza a virus","volume":"107","author":"Acharya","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmb.2016.08.007_bb0170","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/pro.2158","article-title":"Structural basis for proton conduction and inhibition by the influenza M2 protein","volume":"21","author":"Hong","year":"2012","journal-title":"Protein Sci."},{"key":"10.1016\/j.jmb.2016.08.007_bb0175","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.bbamem.2013.07.033","article-title":"Computational and experimental analysis of drug binding to the influenza M2 channel","volume":"1838","author":"Alhadeff","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jmb.2016.08.007_bb0180","article-title":"Molecular surveillance of antiviral drug resistance of influenza A\/H3N2 virus in Singapore, 2009\u20132013","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jmb.2016.08.007_bb0185","doi-asserted-by":"crossref","first-page":"D279","DOI":"10.1093\/nar\/gkv1344","article-title":"The pfam protein families database: towards a more sustainable future","volume":"44","author":"Finn","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmb.2016.08.007_bb0190","doi-asserted-by":"crossref","first-page":"15,409","DOI":"10.1073\/pnas.1009997107","article-title":"Proton and cation transport activity of the m2 proton channel from influenza a virus","volume":"107","author":"Leiding","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmb.2016.08.007_bb0195","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1554-4516(09)10007-8","article-title":"Chapter 7 influenza A M2: channel or transporter?","volume":"10","author":"Busath","year":"2009","journal-title":"Adv. Planar Lipid Bilayers Liposomes"},{"key":"10.1016\/j.jmb.2016.08.007_bb0200","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0378-1119(88)90440-4","article-title":"Tightly regulated tac promoter vectors useful for the expression of unfused and fused proteins in Escherichia coli","volume":"69","author":"Amann","year":"1988","journal-title":"Gene"},{"key":"10.1016\/j.jmb.2016.08.007_bb0205","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/jb.62.3.293-300.1951","article-title":"Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli","volume":"62","author":"Bertani","year":"1951","journal-title":"J. Bacteriol."}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283616303023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283616303023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T21:06:00Z","timestamp":1657055160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283616303023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":41,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0022283616303023"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2016.08.007","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}